Please use this identifier to cite or link to this item: https://hdl.handle.net/10321/42
DC FieldValueLanguage
dc.contributor.advisorMadurai, S.-
dc.contributor.advisorAdam, Jamila Khatoon-
dc.contributor.authorMkhize, Brenda Thabisileen_US
dc.date.accessioned2007-10-12T08:23:45Z
dc.date.available2007-10-12T08:23:45Z
dc.date.issued2007-
dc.identifier.other307247-
dc.identifier.urihttp://hdl.handle.net/10321/42-
dc.descriptionA thesis submitted in partial fulfillment of tine requirements for the Degree of Master of Technology: Biomedical Technology, Durban University of Technology, Durban, South Africa 2007.en_US
dc.description.abstractIn 2004, it was reported that KwaZulu-Natal had the greatest number of HIV infected people, approximately 1.8 million people, of whom an estimated 450 000 were in need of antiretroviral drug therapy based on their Cluster of Differentiation 4 (CD4) counts and clinical status. Studies on the success of antiretroviral drugs in improving the quality of life in HIV infected individuals have been extensively performed and published. However, there are no published data on the effect that immune boosters have in improving the quality of life in such persons. Considering the side effects, toxicity, multi-drug regimens and drug resistance problems associated with antiretroviral therapy, alternative or supplementary therapies may play an important role in improving the quality of life in HIV infected people. Such therapy might help in situations where some patients who qualify for antiretroviral treatment are unable to access them because of several reasons such as long waiting lists, travelling costs, unwilling to take antiretroviral drugs, etc. Some patients have reservations in taking antiretroviral drugs. The stigma associated with the disease may be a major factor. The aim of this study was to investigate the change in the immune status of HIV infected patients that were on the Inochi New Medicine immune booster, as well as, to assess the safety and efficacy of this immune booster in improving the patients’ quality of life.en_US
dc.format.extent268 pen_US
dc.language.isoenen_US
dc.subject.lcshAIDS (Disease)--Immunotherapyen_US
dc.subject.lcshAIDS (Disease)--Immunotherapyen_US
dc.subject.lcshAIDS (Disease)--Alternative treatmenten_US
dc.subject.lcshAntiretroviral agentsen_US
dc.subject.lcshImmunotherapyen_US
dc.subject.lcshAntiviral agents--Therapeutic useen_US
dc.subject.lcshHerbs--Therapeutic useen_US
dc.titleAn investigation of the rate of change of CD4 and CD8 T lymphocyte counts and viral loads in HIV infected patients on immune boostersen_US
dc.typeThesisen_US
dc.description.levelMen_US
dc.identifier.doihttps://doi.org/10.51415/10321/42-
local.sdgSDG03-
item.languageiso639-1en-
item.openairetypeThesis-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:Theses and dissertations (Health Sciences)
Files in This Item:
File Description SizeFormat
Mkhize_2007.pdf3.54 MBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s) 20

1,227
checked on Dec 22, 2024

Download(s)

362
checked on Dec 22, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.